Arcapita Completes TLC Sale

Arcapita has completed its sale of TLC Health Care Services Inc. to Amerdisys Inc. (AMED), for an enterprise value of $395 million. TLC is a Lake Success, N.Y.-based provider of home healthcare services in 22 states. Navigant Capital Advisors advised TLC on the deal.

 

ORIGINAL PRESS RELEASE

Arcapita Inc., a leading private equity investment firm based in Atlanta, announced today that it and its affiliates have agreed to sell TLC Health Care Services, Inc. to Amedisys, Inc., a publicly traded company (Nasdaq: AMED), for an enterprise value of $395 million.

 

Founded in 1978 and headquartered in Lake Success, New York, TLC is the largest privately-held home healthcare provider in the United States, with 92 home health and 11 hospice agencies located in 22 states and the District of Columbia. TLC's licensed healthcare professionals provide a wide range of skilled nursing services, including disease management, cardiac care, behavioral healthcare, and patient and family healthcare counseling. In addition, the company offers home health aide services to assist with activities of daily living.

 

“We are pleased to announce this agreement to sell TLC, the eleventh successful exit from our U.S. corporate portfolio to date,” said Charles H. Ogburn, Arcapita's Global Head of Corporate Investment. “We are delighted with the partnership we have enjoyed with Ed Casas, Executive Chairman, Wes Perry, CEO, and the entire TLC management team.”

 

Jack Draughon, leader of Arcapita's healthcare investment practice, added, “This is a proud day for the TLC management team. Three years ago, we partnered with them to purchase the TLC assets out of bankruptcy, and this agreement is a validation of their vision and execution. On completion, the TLC sale will represent the fourth successful exit from Arcapita's healthcare investment practice.”

 

“The TLC management team has enjoyed a very constructive relationship with Arcapita over the past three years,” stated TLC Executive Chairman Ed Casas. “During this time, we have successfully executed our business plan, and are pleased that Amedisys, a market leader, is recognizing the value that we have created. We are excited about this opportunity to join Amedisys, which we believe is a good platform for further growth of our business.”

Navigant Capital Advisors provided consulting and advisory services to TLC and King & Spalding served as legal advisor on the transaction.

 

About Arcapita

Arcapita is a global investment group with offices in Atlanta, Bahrain, London and Singapore. Arcapita's main lines of business include corporate investment (private equity), real estate investment, asset-based investment, and venture capital. Arcapita's corporate investment line of business was founded in 1997, operates out of Atlanta, London and Bahrain and seeks transactions valued between $200 million and $1 billion with equity investments between $100 million and $300 million. To date, Arcapita has completed 66 transactions with a total value of more than $22 billion. More information on Arcapita is available online at www.arcapita.com .

 

About Amedisys

Amedisys is a leading provider of home healthcare and hospice services, with agencies located across the United States and Puerto Rico. The company was incorporated in 1982. In 1994, the company became public and currently trades on The Nasdaq Market under the symbol “AMED.” More information on Amedisys is available online at www.amedisys.com .